These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2939527

  • 21. Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland.
    Steffen R, Somaini B.
    Lancet; 1986 Mar 15; 1(8481):610. PubMed ID: 2869315
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Leads from the MMWR. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
    JAMA; 1985 May 03; 253(17):2483-6. PubMed ID: 3157011
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Guillain-Barré syndrome associated with Fansidar intake].
    Lorentzon B.
    Lakartidningen; 1984 Aug 22; 81(34):2919. PubMed ID: 6471983
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar).
    Selby CD, Ladusans EJ, Smith PG.
    Br Med J (Clin Res Ed); 1985 Jan 12; 290(6462):113-4. PubMed ID: 3155635
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
    Pearson RD, Hewlett EL.
    Ann Intern Med; 1987 May 12; 106(5):714-8. PubMed ID: 3551713
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Fansidar-induced maculopathy and dermatitis exfoliativa].
    Elsås T, Hallan H.
    Tidsskr Nor Laegeforen; 1987 May 20; 107(14):1231-2. PubMed ID: 2955547
    [No Abstract] [Full Text] [Related]

  • 40. Fansidar-associated fatal reaction in an HIV-infected man.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1988 Sep 23; 37(37):571-2, 577. PubMed ID: 3137443
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.